For the full list of 65@65 facts click here
According to Turkish media, the 67-year-old Turkish politician was treated at Tel Aviv’s International Center for Cell Therapy & Cancer Immunotherapy (CTCI) for almost two and a half months.
Chronic renal disease, also known as chronic kidney disease, is a common condition of the worsening and loss of the kidney function. The kidney disease can be treated with a form of dialysis or by a kidney transplant. However, Israel’s groundbreaking methods in stem cell treatments of the disease may help Unakitan avoid a kidney transplant and cease dialysis treatments.
Turkish media reports indicate that Unakitan will visit Israel again for additional treatments in the future.
Israel’s highly advanced medical innovations and treatments have been utilized by patients across the Middle East. The Jewish state has opened its doors to patients of adversary countries, including Iraq and Iran. In 2008, Israel treated a 12-year-old boy from Iran suffering from a brain tumor.
In August 2012, the husband of Suhila Abd el Salam, the sister of Hamas Prime Minister Ismail Haniyeh, was admitted to Beilinson Hospital in Petach Tikva for immediate medical treatment following a serious heart condition. Haniyeh’s brother-in-law opted to come to Israel instead of Egypt for treatment and was transferred at the Gaza border by a Magen David Adom Ambulance.
For the full list of 65@65 facts click here
Intel’s Israeli subsidiary more than doubled its exports in 2012 to $4.6 billion and is now hoping to bring manufacturing of the company’s next generation of chips to Israel.
At an annual press conference on Sunday (February 17), Intel Israel’s top brass said that the Intel Corporation has invested $10.5 billion in Israel over the past decade.
Intel Israel president Mooly Eden said the company accounted for 20 percent of Israel’s high-tech exports last year and 10 percent of its industrial exports, excluding diamonds. Intel Israel was responsible for a third of Israel’s exports to China.
“Were it not for Intel’s improved performance last year, Israel’s high-tech exports would have fallen by 10 percent,” he told the press conference.
Intel Israel’s top dogs also spoke about the company’s future. The world’s No. 1 chipmaker is currently building chips with features measuring just 14-nanometer in Ireland and the US. But Intel Israel executives want to see 10-nm production in Israel in the coming years.
“The average life of a technology is two to six years so we need to be busy to get the next technology, 10 nanometer,” Maxine Fassberg, general manager of Intel Israel, told the press conference. “We need to get a decision far enough in advance to be able to upgrade the plant. So for 10 nanometer, decisions will need to be made this year.”
Fassberg said the company has received $1.3 billion in government grants in the past. To manufacture 10-nm, she said the Fab 28 plant in Kiryat Gat would need a several billion dollars upgrade.
Samsung is putting Israel on the map again: The global technology giant on Tuesday launched its new initiative, an international innovation and strategy center. The center’s headquarters will be located in Menlo Park in California’s Silicon Valley, but it will have two branches – one in South Korea (Samsung’s country of origin) and one in the central Israeli city of Ramat Gan.
The new center will be headed by Young Sohn, Samsung’s chief strategy officer, who was appointed just four months ago. Yedioth Ahronoth has learned that Young Sohn visited Israel two weeks ago and that this week’s announcement is a direct result of that visit.
The innovation center’s Israeli branch will be established under Samsung Semiconductor’s existing research and development center in Ramat Gan. Samsung executives are said to be extremely satisfied with the R&D center’s performance and results, which have prompted them to open one of the new initiative’s branches in Israel.
The new center is part of Samsung’s comprehensive strategic plan aimed at increasing investment in research and development.
The Israeli technology Samsung plans to invest in will eventually reach the company’s future products.
Samsung’s new investments in Israel, as part of the innovation and strategy center, will focus on three areas: Investment in young Israeli startup companies, whether through a direct investment of capital or through active cooperation aimed at advancing developments and technologies matching Samsung’s future plans; investment in the Israeli academia, whether by funding research being conducted in the country’s universities or by taking ideas and studies created in the academia and developing them into a company and product in collaboration with the R&D center in Ramat Gan; and investment in local venture capital funds investing in Israeli startups.
Employees at Samsung Semiconductor’s R&D center in Ramat Gan have been holding intensive rounds of meetings with many companies in recent months in an attempt to find the suitable candidates for cooperation and investments.
The new center will in fact be a wing of Global Samsung, through which the company will expand its activity in Israel. Acquisitions of local companies may follow, according to estimates.
Young Sohn said in a press conference in Silicon Valley on Tuesday that the company was likely to carry out both major and small acquisitions in the near future.
The technologies the new center will focus on will not necessarily be smartphones and tablets, but would rather be part of a long-term outlook: LED screens, medical products, cloud technologies, data protection and other technologies meant to serve as growth engines for the company.
The semiconductor center, for example, does not develop chips but rather sensors for cameras and phones, digital picture processors and technologies in the field of computer vision.
Samsung is basically trying to become a leading company which reinvents new technological fields and categories. The decision to establish one of its innovation centers in the Jewish state implies that it is going to do so using Israeli technology.
The volume of Samsung’s financial investment in Israel will be determined according to the number of projects and investments. But the potential is clearly huge: Samsung has announced the start of a new $100-billion investment fund, which will invest in larger companies as well. Part of this money will also reach Israel.
In fact, Samsung is conveying the message that it has available money for the Israeli market and that the projects for investment must be found.
Samsung’s relationship with Israel has been particularly strong for many years now. Apart from the R&D center in Ramat Gan, which employs some 200 workers and is based on the Transchip company acquired by Samsung in 2007, there is another R&D center in Yakum, alongside the marketing activity and import of the company’s products.
The Technion – Israel Institute of Technology, one of the world’s top institutions of its kind, has announced the October 2013 launch of the international “Start-uP MBA” program.
The leading Israeli institution will offer a prestigious MBA degree which embodies Israeli entrepreneurship and innovation in the “startup nation.”
Exemplifying the highest academic standards fused with real-world applications, the Technion’s Start-uP MBA program incorporates in-demand internships in startup companies and exposes students to multinational high-tech corporations operating in and around Tel Aviv, Israel’s business hub.
The program will be taught in English by distinguished, world-class Technion professors, internationally-renowned guest lecturers and entrepreneurs with proven track records in one of the world’s most thriving innovation centers.
As the only Israeli member in Yale University’s Global Network for Advanced Management, the Technion’s Start-uP MBA program will leverage international collaborations with leading business schools around the world. The program will also benefit from the Technion’s joint venture with Cornell University.
The Start-uP MBA’s exclusive model was developed by the Technion following intensive market research and consultations with CEOs, entrepreneurs and MBA students, who indicated the need for managerial training that offers a relevant and resilient toolkit for entrepreneurs and managers engaged in technology management and innovation.
As a result, the Start-uP MBA program will involve students in practical projects and internships in start-up companies to augment essential training in management functions.
The program emphasizes the skills needed for entrepreneurs focused on launching start-up companies and for managers seeking to promote entrepreneurship and innovation within their organizations.
The one-year international MBA program is open to candidates with two years of professional post-undergraduate experience and will be taught at a new Technion campus in Tel Aviv.
”The entrepreneurial and innovative spirit is embedded in the DNA of Israeli culture, and combined with the scientific and technological strengths of the Technion, the Start-uP MBA program will offer significant added value to graduates,” said Professor Miriam Erez, vice dean of MBA programs at the Technion.
“As the original start-up nation, Israel has nurtured numerous successful companies over the past decades,” added Professor Dovev Lavie. “Many of these businesses are led by Technion graduates. We offer unparalleled insight and provide students from around the globe with first-hand experience in entrepreneurship and innovation.”
The Start-uP MBA program integrates the Israeli experience in business and technology management, offering knowledge and skills that are essential for global competition in the 21st century.
Israel boasts more high-tech start-ups and venture capital activity per capita than any other nation in the world. In absolute numbers, Israel has produced more start-up companies than larger industrialized countries such as Japan, China, India, the United Kingdom, Canada and South Korea.
Israel has more companies listed on NASDAQ than those from all of Europe, Japan, China, India, South Korea and Singapore combined.